MILLER RICHARD A MD
SEC CIK 1031847 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | Pres, CEO, Dir | 1.20M | $1.27M | — | 12 | 2021-08-20 | 2026-05-18 |
Most active insiders at CRVS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moore David Scott | Dir | $250.2K | — |
| 2 | MILLER RICHARD A MD | Pres, CEO, Dir | $83.5K | — |
| 3 | Thompson Peter A. | Dir, 10% | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-05-20 16:12 | 2026-05-18 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $12.04 | +6,932 | 1.20M | +0.6% | +$83.5K |
| D | 2025-05-09 | 2025-05-07 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | M - OptEx | $3.50 | +559.1K | 1.14M | +97% | +$1.96M |
| I | 2024-05-14 | 2024-05-10 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | G - Gift | $0.00 | -302.0K | 1.19M | -20% | $0 |
| D | 2024-05-07 | 2024-05-06 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.73 | +577.6K | 577.6K | New | +$999.3K |
| MI | 2022-12-15 | 2022-12-13+ | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.7467 | +60.0K | 1.49M | +4% | +$44.8K |
| I | 2022-09-28 | 2022-09-28 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.76 | +25.0K | 1.39M | +2% | +$19.0K |
| MI | 2022-09-20 | 2022-09-20 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.8138 | +20.0K | 1.36M | +1% | +$16.3K |
| MI | 2022-06-28 | 2022-06-24+ | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.01 | +10.0K | 1.35M | +0.7% | +$10.1K |
| MI | 2022-06-06 | 2022-06-02+ | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $0.9842 | +5,890 | 1.34M | +0.4% | +$5,797 |
| I | 2022-04-01 | 2022-03-31 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.64 | +15.0K | 1.33M | +1% | +$24.6K |
| MI | 2022-03-17 | 2022-03-15+ | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.49 | +30.0K | 1.31M | +2% | +$44.7K |
| I | 2021-08-23 | 2021-08-20 | CRVS | Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Pres, CEO, Dir | P - Purchase | $1.93 | +10.0K | 1.29M | +0.8% | +$19.3K |
Purchase Sale Sale after option exercise All abbreviations